Hospital
HH Health System - Marshall LLC
HH Health System - Marshall LLC was paid $6.91M by Medicaid between Oct 2019 and Dec 2024, across 129 billing codes. Its largest line is 99284, emergency room visit (serious) — 35% of everything it billed.
33Billing provider infoHH HEALTH SYSTEM - MARSHALL LLC
BOAZ, AL 35957
BOAZ, AL 35957
33aNPI1407313760assigned 02/22/2019
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.91M
24GClaims341,312
24DCodes billed129
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Alabama
Rank by total paid#7 of 77
Median peer was paid$1.13M
This provider vs. median6.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 13,697 | $122K | |
| 2020 | 59,904 | $959K | |
| 2021 | 60,510 | $1.15M | |
| 2022 | 63,108 | $1.35M | |
| 2023 | 89,516 | $1.96M | |
| 2024incomplete | 54,577 | $1.37M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 35% | 37,779 | 32,904 | $2.42M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 36,794 | 31,162 | $1.37M |
| 80053 | Comprehensive metabolic panel | 6.4% | 41,550 | 35,471 | $445K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.6% | 46,111 | 38,780 | $386K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 5.4% | 11,241 | 9,136 | $373K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.0% | 20,307 | 13,189 | $346K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.0% | 5,514 | 3,297 | $141K |
| 80061 | Lipid panel | 2.0% | 8,488 | 7,710 | $140K |
| 87561 | 2.0% | 4,335 | 3,288 | $135K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.7% | 11,333 | 9,556 | $119K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.4% | 5,860 | 5,301 | $95K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.2% | 6,343 | 5,760 | $83K |
117 more codes
| D9420 | <1% | 268 | $56K | |
| 81003 | <1% | 19,520 | $52K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,701 | $51K |
| 80055 | <1% | 629 | $45K | |
| 86780 | <1% | 2,226 | $39K | |
| 80305 | <1% | 4,065 | $38K | |
| 87081 | <1% | 3,212 | $33K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,951 | $27K |
| 59025 | Fetal non-stress test | <1% | 6,074 | $27K |
| 87420 | <1% | 2,024 | $25K | |
| 82607 | <1% | 1,282 | $22K | |
| 87430 | <1% | 2,374 | $21K | |
| 86701 | <1% | 1,745 | $20K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,596 | $17K |
| 86850 | <1% | 2,754 | $17K | |
| 85027 | <1% | 3,918 | $17K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 132 | $17K |
| 86762 | <1% | 835 | $16K | |
| 82746 | <1% | 1,132 | $15K | |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | <1% | 12 | $14K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,088 | $14K |
| 74022 | <1% | 551 | $13K | |
| G0378 | Hospital observation service, per hour | <1% | 226 | $12K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,259 | $12K |
| 84481 | <1% | 671 | $11K | |
| 87340 | <1% | 875 | $11K | |
| 81025 | <1% | 3,171 | $11K | |
| 93970 | <1% | 366 | $11K | |
| 83690 | <1% | 1,361 | $10K | |
| 82105 | <1% | 375 | $8K | |
| 82950 | <1% | 1,280 | $8K | |
| 84439 | <1% | 807 | $8K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 97 | $8K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 35 | $7K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,099 | $7K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 13 | $7K |
| 83605 | <1% | 731 | $6K | |
| 84702 | <1% | 578 | $6K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,516 | $6K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 170 | $6K |
| 87070 | <1% | 489 | $5K | |
| 86592 | <1% | 1,104 | $5K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 38 | $5K |
| 84484 | <1% | 689 | $4K | |
| 86901 | <1% | 1,550 | $4K | |
| 82150 | <1% | 587 | $4K | |
| 82728 | <1% | 401 | $4K | |
| 86900 | <1% | 1,368 | $4K | |
| 83550 | <1% | 226 | $3K | |
| 97014 | <1% | 428 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 187 | $3K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $3K |
| 93925 | <1% | 75 | $3K | |
| 80164 | <1% | 121 | $3K | |
| 86803 | <1% | 163 | $3K | |
| 84703 | <1% | 409 | $2K | |
| 97161 | <1% | 53 | $2K | |
| 83540 | <1% | 243 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 52 | $2K |
| 85610 | <1% | 628 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 83 | $2K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 19 | $2K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 23 | $2K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 13 | $2K |
| 85651 | <1% | 383 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 53 | $2K |
| 82550 | <1% | 320 | $2K | |
| 83655 | <1% | 138 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 52 | $1K |
| 82570 | <1% | 116 | $887.00 | |
| 85014 | <1% | 280 | $876.06 | |
| 85018 | <1% | 279 | $871.48 | |
| 83735 | <1% | 129 | $853.96 | |
| 82947 | <1% | 172 | $792.81 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 684 | $771.34 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 12 | $704.82 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 49 | $700.00 |
| 85730 | <1% | 356 | $635.08 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 52 | $631.56 |
| 86140 | <1% | 326 | $596.25 | |
| 84156 | <1% | 116 | $593.00 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 15 | $560.17 |
| 70486 | <1% | 18 | $528.42 | |
| 99285 | Emergency room visit (most serious) | <1% | 16 | $473.49 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 340 | $470.68 |
| 83021 | <1% | 21 | $414.97 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 79 | $395.64 |
| 80069 | <1% | 47 | $375.36 | |
| 87186 | <1% | 45 | $366.55 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $341.04 |
| 80047 | <1% | 59 | $280.60 | |
| 82043 | <1% | 49 | $266.80 | |
| 81001 | <1% | 72 | $254.49 | |
| 87040 | <1% | 46 | $218.01 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 40 | $215.68 |
| 80076 | <1% | 36 | $213.40 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 648 | $154.67 |
| 87077 | <1% | 14 | $143.68 | |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 2,183 | $132.23 |
| 85660 | <1% | 21 | $120.53 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 251 | $96.47 |
| A0425 | Ground mileage, per statute mile | <1% | 5,226 | $84.54 |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,457 | $76.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 15 | $69.03 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 49 | $33.59 |
| 81015 | <1% | 13 | $9.09 | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 0% | 2,128 | $0.00 |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 0% | 91 | $0.00 |
| 93018 | 0% | 15 | $0.00 | |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | 0% | 151 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 13 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 14 | $0.00 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 1,921 | $0.00 |
| 80364 | 0% | 65 | $0.00 | |
| 80347 | 0% | 65 | $0.00 | |
| A0429 | Emergency ambulance ride, basic life support | 0% | 158 | $0.00 |
| 80326 | 0% | 65 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWALKER, TAYLOR (CFO)
| Provider | Location | Paid |
|---|---|---|
| Houston Northwest Operating Company, LLC | Houston, TX | $18.38M |
| Northwest Medical Center INC | Margate, FL | $7.93M |
| HH Health System - Marshall LLC | Guntersville, AL | $954K |
| Marshall Medical Center South | Boaz, AL | $771K |
| Northeast Alabama Vascular and Vein Specialist | Albertville, AL | $26K |
| Neurology of Marshall County | Guntersville, AL | $13K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.